MedTrace Logo

The Effect of White Tea in Healthy Human Subjects

NCT07344688 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2026-04-17

No results posted yet for this study

Summary

This clinical study aims to determine the effects of consuming white tea infusion (Camellia sinensis) on healthy subjects over a period of 14 days. The main questions it aims to answer are:

1. Determine the effect of white tea consumption on the anthropometry of healthy subjects.
2. Determine the effect of white tea consumption on the biochemical parameters of healthy subjects.
3. Determine the effect of white tea consumption on hematology parameters that are related to anemia case in healthy subjects.
4. Determine the effect of white tea consumption on the activity of first-line antioxidant enzymes in healthy subjects

Researchers used only one treatment group, and respondents knew which treatment they would receive (single-arm and open-labelled), namely white tea infusion to maintain human body health. Participants will:

1. Follow the washout stage for 7 days
2. Drink white tea infusion every day for 14 days.
3. Follow up to monitor adverse effects after consuming white tea; this stage will be conducted for 7 days.
4. Report all food and beverages consumed by respondents during the study.

Conditions

  • Healhty

Interventions

OTHER

White tea intervention

1. White tea infusion was prepared by brewing 4 grams of white tea in 200 mL of hot water. 2. Healthy respondents were asked to consume the white tea infusion for 14 days. 3. The focus of this study was to observe the effect of white tea infusion on antioxidant enzyme activity and its relationship with anthropometric, biochemical, and haematological parameters.

Sponsors & Collaborators

  • Universitas Padjadjaran

    lead OTHER

Principal Investigators

  • Gofarana Wilar, Ph.D. · Faculty of Pharmacy, Universitas Padjadjaran, Bandung, Indonesia

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-22
Primary Completion
2025-09-27
Completion
2025-12-30

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07344688 on ClinicalTrials.gov